IP Verse

Drug Delivery Systems And Methods For Treatment Of Bladder Cancer With Gemcitabine

Patent No. EP4124339 (titled "Drug Delivery Systems And Methods For Treatment Of Bladder Cancer With Gemcitabine") was filed by Taris Biomedical on Mar 6, 2015. The application was issued on Sep 10, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBBJun 10, 2026GRUND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4124339

TARIS BIOMEDICAL
Application Number
EP22196596A
Filing Date
Mar 6, 2015
Status
Granted And Under Opposition
Aug 8, 2025
Publication Date
Sep 10, 2025
External Links
Slate, Register , Google Patents